 | • レポートコード：MRC2-11QY13058 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は白斑治療薬のグローバル市場について調査・分析したレポートです。種類別（ARN-4079、ATI-50001、AX-1602、リン酸ルキソリチニブ、VLRX-001、その他）市場規模、用途別（診療所、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別白斑治療薬の競争状況、市場シェア ・世界の白斑治療薬市場：種類別市場規模 2015年-2020年（ARN-4079、ATI-50001、AX-1602、リン酸ルキソリチニブ、VLRX-001、その他） ・世界の白斑治療薬市場：種類別市場規模予測 2021年-2026年（ARN-4079、ATI-50001、AX-1602、リン酸ルキソリチニブ、VLRX-001、その他） ・世界の白斑治療薬市場：用途別市場規模 2015年-2020年（診療所、病院、その他） ・世界の白斑治療薬市場：用途別市場規模予測 2021年-2026年（診療所、病院、その他） ・北米の白斑治療薬市場分析：米国、カナダ ・ヨーロッパの白斑治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの白斑治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の白斑治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの白斑治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Aclaris Therapeutics Inc、Arrien Pharmaceuticals LLC、Bristol-Myers Squibb Co、Celgene Corp、Clinuvel Pharmaceuticals Ltd、Incyte Corp ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Vitiligo Drug Market
The global Vitiligo Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Vitiligo Drug Scope and Market Size
Vitiligo Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Vitiligo Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Vitiligo Drug market is segmented into
ARN-4079
ATI-50001
AX-1602
Ruxolitinib Phosphate
VLRX-001
Others
Segment by Application, the Vitiligo Drug market is segmented into
Clinic
Hospital
Others
Regional and Country-level Analysis
The Vitiligo Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Vitiligo Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Vitiligo Drug Market Share Analysis
Vitiligo Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Vitiligo Drug business, the date to enter into the Vitiligo Drug market, Vitiligo Drug product introduction, recent developments, etc.
The major vendors covered:
Aclaris Therapeutics Inc
Arrien Pharmaceuticals LLC
Bristol-Myers Squibb Co
Celgene Corp
Clinuvel Pharmaceuticals Ltd
Incyte Corp
…
1 Study Coverage
1.1 Vitiligo Drug Product Introduction
1.2 Market Segments
1.3 Key Vitiligo Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Vitiligo Drug Market Size Growth Rate by Type
1.4.2 ARN-4079
1.4.3 ATI-50001
1.4.4 AX-1602
1.4.5 Ruxolitinib Phosphate
1.4.6 VLRX-001
1.4.7 Others
1.5 Market by Application
1.5.1 Global Vitiligo Drug Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Vitiligo Drug Market Size, Estimates and Forecasts
2.1.1 Global Vitiligo Drug Revenue 2015-2026
2.1.2 Global Vitiligo Drug Sales 2015-2026
2.2 Global Vitiligo Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Vitiligo Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Vitiligo Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Vitiligo Drug Competitor Landscape by Players
3.1 Vitiligo Drug Sales by Manufacturers
3.1.1 Vitiligo Drug Sales by Manufacturers (2015-2020)
3.1.2 Vitiligo Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Vitiligo Drug Revenue by Manufacturers
3.2.1 Vitiligo Drug Revenue by Manufacturers (2015-2020)
3.2.2 Vitiligo Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Vitiligo Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Vitiligo Drug Revenue in 2019
3.2.5 Global Vitiligo Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Vitiligo Drug Price by Manufacturers
3.4 Vitiligo Drug Manufacturing Base Distribution, Product Types
3.4.1 Vitiligo Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Vitiligo Drug Product Type
3.4.3 Date of International Manufacturers Enter into Vitiligo Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Vitiligo Drug Market Size by Type (2015-2020)
4.1.1 Global Vitiligo Drug Sales by Type (2015-2020)
4.1.2 Global Vitiligo Drug Revenue by Type (2015-2020)
4.1.3 Vitiligo Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Vitiligo Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Vitiligo Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Vitiligo Drug Revenue Forecast by Type (2021-2026)
4.2.3 Vitiligo Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Vitiligo Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Vitiligo Drug Market Size by Application (2015-2020)
5.1.1 Global Vitiligo Drug Sales by Application (2015-2020)
5.1.2 Global Vitiligo Drug Revenue by Application (2015-2020)
5.1.3 Vitiligo Drug Price by Application (2015-2020)
5.2 Vitiligo Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Vitiligo Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Vitiligo Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Vitiligo Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Vitiligo Drug by Country
6.1.1 North America Vitiligo Drug Sales by Country
6.1.2 North America Vitiligo Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Vitiligo Drug Market Facts & Figures by Type
6.3 North America Vitiligo Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Vitiligo Drug by Country
7.1.1 Europe Vitiligo Drug Sales by Country
7.1.2 Europe Vitiligo Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Vitiligo Drug Market Facts & Figures by Type
7.3 Europe Vitiligo Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Vitiligo Drug by Region
8.1.1 Asia Pacific Vitiligo Drug Sales by Region
8.1.2 Asia Pacific Vitiligo Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Vitiligo Drug Market Facts & Figures by Type
8.3 Asia Pacific Vitiligo Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Vitiligo Drug by Country
9.1.1 Latin America Vitiligo Drug Sales by Country
9.1.2 Latin America Vitiligo Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Vitiligo Drug Market Facts & Figures by Type
9.3 Central & South America Vitiligo Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Vitiligo Drug by Country
10.1.1 Middle East and Africa Vitiligo Drug Sales by Country
10.1.2 Middle East and Africa Vitiligo Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Vitiligo Drug Market Facts & Figures by Type
10.3 Middle East and Africa Vitiligo Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Aclaris Therapeutics Inc
11.1.1 Aclaris Therapeutics Inc Corporation Information
11.1.2 Aclaris Therapeutics Inc Description and Business Overview
11.1.3 Aclaris Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aclaris Therapeutics Inc Vitiligo Drug Products Offered
11.1.5 Aclaris Therapeutics Inc Related Developments
11.2 Arrien Pharmaceuticals LLC
11.2.1 Arrien Pharmaceuticals LLC Corporation Information
11.2.2 Arrien Pharmaceuticals LLC Description and Business Overview
11.2.3 Arrien Pharmaceuticals LLC Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Arrien Pharmaceuticals LLC Vitiligo Drug Products Offered
11.2.5 Arrien Pharmaceuticals LLC Related Developments
11.3 Bristol-Myers Squibb Co
11.3.1 Bristol-Myers Squibb Co Corporation Information
11.3.2 Bristol-Myers Squibb Co Description and Business Overview
11.3.3 Bristol-Myers Squibb Co Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bristol-Myers Squibb Co Vitiligo Drug Products Offered
11.3.5 Bristol-Myers Squibb Co Related Developments
11.4 Celgene Corp
11.4.1 Celgene Corp Corporation Information
11.4.2 Celgene Corp Description and Business Overview
11.4.3 Celgene Corp Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Celgene Corp Vitiligo Drug Products Offered
11.4.5 Celgene Corp Related Developments
11.5 Clinuvel Pharmaceuticals Ltd
11.5.1 Clinuvel Pharmaceuticals Ltd Corporation Information
11.5.2 Clinuvel Pharmaceuticals Ltd Description and Business Overview
11.5.3 Clinuvel Pharmaceuticals Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Clinuvel Pharmaceuticals Ltd Vitiligo Drug Products Offered
11.5.5 Clinuvel Pharmaceuticals Ltd Related Developments
11.6 Incyte Corp
11.6.1 Incyte Corp Corporation Information
11.6.2 Incyte Corp Description and Business Overview
11.6.3 Incyte Corp Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Incyte Corp Vitiligo Drug Products Offered
11.6.5 Incyte Corp Related Developments
11.1 Aclaris Therapeutics Inc
11.1.1 Aclaris Therapeutics Inc Corporation Information
11.1.2 Aclaris Therapeutics Inc Description and Business Overview
11.1.3 Aclaris Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aclaris Therapeutics Inc Vitiligo Drug Products Offered
11.1.5 Aclaris Therapeutics Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Vitiligo Drug Market Estimates and Projections by Region
12.1.1 Global Vitiligo Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Vitiligo Drug Revenue Forecast by Regions 2021-2026
12.2 North America Vitiligo Drug Market Size Forecast (2021-2026)
12.2.1 North America: Vitiligo Drug Sales Forecast (2021-2026)
12.2.2 North America: Vitiligo Drug Revenue Forecast (2021-2026)
12.2.3 North America: Vitiligo Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Vitiligo Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Vitiligo Drug Sales Forecast (2021-2026)
12.3.2 Europe: Vitiligo Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Vitiligo Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Vitiligo Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Vitiligo Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Vitiligo Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Vitiligo Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Vitiligo Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Vitiligo Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Vitiligo Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Vitiligo Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Vitiligo Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Vitiligo Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Vitiligo Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Vitiligo Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Vitiligo Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Vitiligo Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Vitiligo Drug Market Segments
Table 2. Ranking of Global Top Vitiligo Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Vitiligo Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of ARN-4079
Table 5. Major Manufacturers of ATI-50001
Table 6. Major Manufacturers of AX-1602
Table 7. Major Manufacturers of Ruxolitinib Phosphate
Table 8. Major Manufacturers of VLRX-001
Table 9. Major Manufacturers of Others
Table 10. Global Vitiligo Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Vitiligo Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Vitiligo Drug Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Vitiligo Drug Sales Market Share by Regions (2015-2020)
Table 14. Global Vitiligo Drug Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Vitiligo Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Vitiligo Drug Sales Share by Manufacturers (2015-2020)
Table 17. Global Vitiligo Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Vitiligo Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vitiligo Drug as of 2019)
Table 19. Vitiligo Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Vitiligo Drug Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Vitiligo Drug Price (2015-2020) (USD/Pcs)
Table 22. Vitiligo Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Vitiligo Drug Product Type
Table 24. Date of International Manufacturers Enter into Vitiligo Drug Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Vitiligo Drug Sales by Type (2015-2020) (K Pcs)
Table 27. Global Vitiligo Drug Sales Share by Type (2015-2020)
Table 28. Global Vitiligo Drug Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Vitiligo Drug Revenue Share by Type (2015-2020)
Table 30. Vitiligo Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Vitiligo Drug Sales by Application (2015-2020) (K Pcs)
Table 32. Global Vitiligo Drug Sales Share by Application (2015-2020)
Table 33. North America Vitiligo Drug Sales by Country (2015-2020) (K Pcs)
Table 34. North America Vitiligo Drug Sales Market Share by Country (2015-2020)
Table 35. North America Vitiligo Drug Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Vitiligo Drug Revenue Market Share by Country (2015-2020)
Table 37. North America Vitiligo Drug Sales by Type (2015-2020) (K Pcs)
Table 38. North America Vitiligo Drug Sales Market Share by Type (2015-2020)
Table 39. North America Vitiligo Drug Sales by Application (2015-2020) (K Pcs)
Table 40. North America Vitiligo Drug Sales Market Share by Application (2015-2020)
Table 41. Europe Vitiligo Drug Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Vitiligo Drug Sales Market Share by Country (2015-2020)
Table 43. Europe Vitiligo Drug Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Vitiligo Drug Revenue Market Share by Country (2015-2020)
Table 45. Europe Vitiligo Drug Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Vitiligo Drug Sales Market Share by Type (2015-2020)
Table 47. Europe Vitiligo Drug Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Vitiligo Drug Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Vitiligo Drug Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Vitiligo Drug Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Vitiligo Drug Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Vitiligo Drug Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Vitiligo Drug Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Vitiligo Drug Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Vitiligo Drug Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Vitiligo Drug Sales Market Share by Application (2015-2020)
Table 57. Latin America Vitiligo Drug Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Vitiligo Drug Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Vitiligo Drug Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Vitiligo Drug Revenue Market Share by Country (2015-2020)
Table 61. Latin America Vitiligo Drug Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Vitiligo Drug Sales Market Share by Type (2015-2020)
Table 63. Latin America Vitiligo Drug Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Vitiligo Drug Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Vitiligo Drug Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Vitiligo Drug Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Vitiligo Drug Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Vitiligo Drug Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Vitiligo Drug Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Vitiligo Drug Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Vitiligo Drug Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Vitiligo Drug Sales Market Share by Application (2015-2020)
Table 73. Aclaris Therapeutics Inc Corporation Information
Table 74. Aclaris Therapeutics Inc Description and Major Businesses
Table 75. Aclaris Therapeutics Inc Vitiligo Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Aclaris Therapeutics Inc Product
Table 77. Aclaris Therapeutics Inc Recent Development
Table 78. Arrien Pharmaceuticals LLC Corporation Information
Table 79. Arrien Pharmaceuticals LLC Description and Major Businesses
Table 80. Arrien Pharmaceuticals LLC Vitiligo Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Arrien Pharmaceuticals LLC Product
Table 82. Arrien Pharmaceuticals LLC Recent Development
Table 83. Bristol-Myers Squibb Co Corporation Information
Table 84. Bristol-Myers Squibb Co Description and Major Businesses
Table 85. Bristol-Myers Squibb Co Vitiligo Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Bristol-Myers Squibb Co Product
Table 87. Bristol-Myers Squibb Co Recent Development
Table 88. Celgene Corp Corporation Information
Table 89. Celgene Corp Description and Major Businesses
Table 90. Celgene Corp Vitiligo Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Celgene Corp Product
Table 92. Celgene Corp Recent Development
Table 93. Clinuvel Pharmaceuticals Ltd Corporation Information
Table 94. Clinuvel Pharmaceuticals Ltd Description and Major Businesses
Table 95. Clinuvel Pharmaceuticals Ltd Vitiligo Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Clinuvel Pharmaceuticals Ltd Product
Table 97. Clinuvel Pharmaceuticals Ltd Recent Development
Table 98. Incyte Corp Corporation Information
Table 99. Incyte Corp Description and Major Businesses
Table 100. Incyte Corp Vitiligo Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Incyte Corp Product
Table 102. Incyte Corp Recent Development
Table 103. Global Vitiligo Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 104. Global Vitiligo Drug Sales Market Share Forecast by Regions (2021-2026)
Table 105. Global Vitiligo Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 106. Global Vitiligo Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 107. North America: Vitiligo Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 108. North America: Vitiligo Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Europe: Vitiligo Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 110. Europe: Vitiligo Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Asia Pacific: Vitiligo Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 112. Asia Pacific: Vitiligo Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 113. Latin America: Vitiligo Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 114. Latin America: Vitiligo Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Middle East and Africa: Vitiligo Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 116. Middle East and Africa: Vitiligo Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 118. Key Challenges
Table 119. Market Risks
Table 120. Main Points Interviewed from Key Vitiligo Drug Players
Table 121. Vitiligo Drug Customers List
Table 122. Vitiligo Drug Distributors List
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Vitiligo Drug Product Picture
Figure 2. Global Vitiligo Drug Sales Market Share by Type in 2020 & 2026
Figure 3. ARN-4079 Product Picture
Figure 4. ATI-50001 Product Picture
Figure 5. AX-1602 Product Picture
Figure 6. Ruxolitinib Phosphate Product Picture
Figure 7. VLRX-001 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Vitiligo Drug Sales Market Share by Application in 2020 & 2026
Figure 10. Clinic
Figure 11. Hospital
Figure 12. Others
Figure 13. Vitiligo Drug Report Years Considered
Figure 14. Global Vitiligo Drug Market Size 2015-2026 (US$ Million)
Figure 15. Global Vitiligo Drug Sales 2015-2026 (K Pcs)
Figure 16. Global Vitiligo Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Vitiligo Drug Sales Market Share by Region (2015-2020)
Figure 18. Global Vitiligo Drug Sales Market Share by Region in 2019
Figure 19. Global Vitiligo Drug Revenue Market Share by Region (2015-2020)
Figure 20. Global Vitiligo Drug Revenue Market Share by Region in 2019
Figure 21. Global Vitiligo Drug Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Vitiligo Drug Revenue in 2019
Figure 23. Vitiligo Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Vitiligo Drug Sales Market Share by Type (2015-2020)
Figure 25. Global Vitiligo Drug Sales Market Share by Type in 2019
Figure 26. Global Vitiligo Drug Revenue Market Share by Type (2015-2020)
Figure 27. Global Vitiligo Drug Revenue Market Share by Type in 2019
Figure 28. Global Vitiligo Drug Market Share by Price Range (2015-2020)
Figure 29. Global Vitiligo Drug Sales Market Share by Application (2015-2020)
Figure 30. Global Vitiligo Drug Sales Market Share by Application in 2019
Figure 31. Global Vitiligo Drug Revenue Market Share by Application (2015-2020)
Figure 32. Global Vitiligo Drug Revenue Market Share by Application in 2019
Figure 33. North America Vitiligo Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Vitiligo Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Vitiligo Drug Sales Market Share by Country in 2019
Figure 36. North America Vitiligo Drug Revenue Market Share by Country in 2019
Figure 37. U.S. Vitiligo Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Vitiligo Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Vitiligo Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Vitiligo Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Vitiligo Drug Market Share by Type in 2019
Figure 42. North America Vitiligo Drug Market Share by Application in 2019
Figure 43. Europe Vitiligo Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Vitiligo Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Vitiligo Drug Sales Market Share by Country in 2019
Figure 46. Europe Vitiligo Drug Revenue Market Share by Country in 2019
Figure 47. Germany Vitiligo Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Vitiligo Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Vitiligo Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Vitiligo Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Vitiligo Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Vitiligo Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Vitiligo Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Vitiligo Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Vitiligo Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Vitiligo Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Vitiligo Drug Market Share by Type in 2019
Figure 58. Europe Vitiligo Drug Market Share by Application in 2019
Figure 59. Asia Pacific Vitiligo Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Vitiligo Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Vitiligo Drug Sales Market Share by Region in 2019
Figure 62. Asia Pacific Vitiligo Drug Revenue Market Share by Region in 2019
Figure 63. China Vitiligo Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Vitiligo Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Vitiligo Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Vitiligo Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Vitiligo Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Vitiligo Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Vitiligo Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Vitiligo Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Vitiligo Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Vitiligo Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Vitiligo Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Vitiligo Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Vitiligo Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Vitiligo Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Vitiligo Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Vitiligo Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Vitiligo Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Vitiligo Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Vitiligo Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Vitiligo Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Vitiligo Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Vitiligo Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Vitiligo Drug Market Share by Type in 2019
Figure 86. Asia Pacific Vitiligo Drug Market Share by Application in 2019
Figure 87. Latin America Vitiligo Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Vitiligo Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Vitiligo Drug Sales Market Share by Country in 2019
Figure 90. Latin America Vitiligo Drug Revenue Market Share by Country in 2019
Figure 91. Mexico Vitiligo Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Vitiligo Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Vitiligo Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Vitiligo Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Vitiligo Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Vitiligo Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Vitiligo Drug Market Share by Type in 2019
Figure 98. Latin America Vitiligo Drug Market Share by Application in 2019
Figure 99. Middle East and Africa Vitiligo Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Vitiligo Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Vitiligo Drug Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Vitiligo Drug Revenue Market Share by Country in 2019
Figure 103. Turkey Vitiligo Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Vitiligo Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Vitiligo Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Vitiligo Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Vitiligo Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Vitiligo Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Vitiligo Drug Market Share by Type in 2019
Figure 110. Middle East and Africa Vitiligo Drug Market Share by Application in 2019
Figure 111. North America Vitiligo Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Vitiligo Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Vitiligo Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Vitiligo Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Vitiligo Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Vitiligo Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Vitiligo Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Vitiligo Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Vitiligo Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Vitiligo Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
小売薬の世界市場（～2026年） A drug is any substance (other than food that provides nutritional support) that, when inhaled, injected, smoked, consumed, absorbed via a patch on the skin, or dissolved under the tongue causes a temporary physiological (and often psychological) change in the body. Increasing industry share of Asia…- 大麻薬の世界市場（～2026年） Drugs with chemicals taken directly from the marijuana plant，or with synthetic versions of chemicals naturally found in marijuana. Market Analysis and Insights: Global Cannabis Drug Market The global Cannabis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020,…
- 乱用薬物検査サービスの世界市場（～2026年） Drug of Abuse Testing Services is the use of testing services to avoid the negative effects of drug abuse, to reduce the accidents. In addition to rise in number of substance abusers and increase in number of government initiatives to avoid ill effects of substance abuse at workplace & reduce number…
- 薬物スクリーニング検査サービスの世界市場（～2026年） Market Analysis and Insights: Global Drug Screening Laboratory Service Market The global Drug Screening Laboratory Service market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…
- 子宮内膜ポリープ治療薬の世界市場（～2026年） Uterine polyps are common gynecological diseases. Broadly speaking, it refers to all tumors attached to the uterine wall by slender pedicle. Mostly benign. Market Analysis and Insights: Global Uterine Polyps Drug Market The global Uterine Polyps Drug market size is projected to reach US$ XX million …